Title  | Date  | Price  |
|---|
Middle East & Africa Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Australia Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Japan Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Belgium Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Spain Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Italy Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
UK Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
France Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Germany Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Republic of Korea Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Israel Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
South & Central America Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Asia Pacific Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Europe Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
North America Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Brazil Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Mexico Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
South Africa Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Egypt Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Canada Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
US Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Global Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,995 |
Netherlands Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Argentina Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,495 |
Stakeholder Insight: Diabetes
| Dec 2007 |
£7,600 |
The World Diabetes Market, 2006-2012, 2017, 2025 A Key Pharmaceutical Market of the Future
| Oct 2007 |
£1,499 |
Pipeline Insight: Antidiabetics - Insulins
| Sep 2007 |
£5,820 |
Blood Glucose Testing and Diabetes Management
| Jul 2007 |
£1,695 |
Diabetes & Obesity A Competitor Analysis
| Mar 2007 |
£675 |
Diabetes and Diabetic Complications Major World Markets, 3rd Ed.
| Mar 2007 |
£1,990 |
Diabetes Drug Discoveries What the Future Holds
| Jan 2007 |
£1,495 |
Diabetes Drug Discoveries What the Future Holds
| Jan 2007 |
£1,495 |
PPAR Agonists Competitor Analysis
| Jan 2007 |
£132 |
Stakeholder Insight: Atherosclerosis HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment
| Dec 2006 |
£8,000 |
Commercial and Pipeline Perspectives: Obesity Lack of Reimbursement Limits Market Potential
| Dec 2006 |
£6,000 |
Stakeholder Insight: Atrial Fibrillation Limited efficacy and poor safety lead to bleak outlook
| Oct 2006 |
£8,000 |
Commercial Insight: Antihypertensives New challenges for a maturing market
| Sep 2006 |
£8,000 |
Pipeline Insight: Insulins Inhalable insulins unlikely to become blockbusters
| Sep 2006 |
£6,000 |
Global Diabetes Market; The Therapeutics, Diagnostics and Complications
| Aug 2006 |
£1,245 |
Insulin Competitor Analysis
| Jun 2006 |
£100 |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
| Oct 2005 |
£995 |
Inhaled Insulin A Market Briefing
| Jul 2004 |
£445 |